UnitedHealth Group Incorporated(UNH)Earnings, Financials & Key RatiosUnitedHealth Group Incorporated (UNH) stock price & volume — 10-year historical chart
Investment Thesis • Updated 2026Q1
while the company maintains a 2.0% dividend yield, the current P/E of 32.34 appears elevated given the recent deceleration in revenue growth to 2.0% and the ongoing volatility in quarterly earnings.
UnitedHealth Group Incorporated (UNH) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
UnitedHealth Group Incorporated (UNH) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Apr 21, 2026 | $7.23vs $6.58+9.9% | $111.7Bvs $109.4B+2.1% |
| Q1 2026 | Jan 27, 2026 | $2.11vs $2.10+0.5% | $113.2Bvs $113.8B-0.5% |
| Q4 2025 | Oct 28, 2025 | $2.92vs $2.80+4.3% | $113.2Bvs $113.0B+0.1% |
| Q3 2025 | Jul 29, 2025 | $4.08vs $4.45-8.3% | $111.6Bvs $111.5B+0.1% |
Recent stock market news and headlines for UnitedHealth Group Incorporated (UNH)
UnitedHealth on Tuesday said an audit by an external consulting firm showed nearly 97% of diagnoses identified within its HouseCalls home-health unit, which has faced scrutiny from lawmakers, were supported by a patient's medical record.
UnitedHealth Group (UNH) concluded the recent trading session at $417.99, signifying a -1.73% move from its prior day's close.
UnitedHealth is prioritizing profitability over rapid growth as improving margins, stronger earnings and Optum expansion aim to support a long-term turnaround.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
These three healthcare stocks provide stability, relatively high dividend yields, and consistent growth.
Key metrics vs top competitors for UnitedHealth Group Incorporated (UNH)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $428.19 | $388.86B | 32.37 | 11.81% | 2.69% | 11.8% | 2.03% | |
| $104.33 | $133.12B | 75.06 | 7.85% | 0.72% | 3.86% | — | |
| $418.85 | $90.96B | 16.67 | 12.62% | 2.62% | 11.92% | — | |
| $286.62 | $75.57B | 12.93 | 11.26% | 2.26% | 15.08% | — | |
| $394.62 | $47.38B | 40.10 | 10.06% | 0.82% | 6.17% | — | |
| $66.12 | $32.65B | -4.85 | 19.44% | -3.25% | -28.6% | — |
UnitedHealth Group Incorporated (UNH) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
UnitedHealth Group Incorporated (UNH) SEC filings — annual & quarterly reports (10-K, 10-Q)
Jun 5, 2026·SEC
May 11, 2026·SEC
Apr 21, 2026·SEC
Get notified when UNH posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
UnitedHealth Group Incorporated (UNH) stock FAQ — growth, dividends, profitability & financials explained
UnitedHealth Group Incorporated (UNH) grew revenue by 11.8% over the past year. This is steady growth.
Yes, UnitedHealth Group Incorporated (UNH) is profitable, generating $12.04B in net income for fiscal year 2025 (2.7% net margin).
Yes, UnitedHealth Group Incorporated (UNH) pays a dividend with a yield of 2.03%. This makes it attractive for income-focused investors.
UnitedHealth Group Incorporated (UNH) has a return on equity (ROE) of 11.8%. This is reasonable for most industries.
UnitedHealth Group Incorporated (UNH) has a combined ratio of 95.8%. A ratio below 100% indicates underwriting profitability.
